Sage Therapeutics Inc (NASDAQ:SAGE) and Biogen Inc (NASDAQ: BIIB) have announced data from WATERFALL Phase 3 study evaluating zuranolone (SAGE-217/BIIB125) in patients with Major…
Wolfe Research analyst Josh Silverstein upgrades Cabot Oil & Gas (NYSE:COG) from Peer Perform to Outperform and raises the price target from $25 to $28.